BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ChinaBio(R) LLC Week in Review: 2012 China Life Science VC, M&A, and Partnering Climb


1/28/2013 9:47:15 AM

by Richard Daverman, PhD

January 26, 2012 -- In 2012, China’s life science’s VC investment, M&A transactions, and partnering activity all rose substantially according to ChinaBio® data; Zhejiang Hisun Pharma in-licensed China rights to ThermoDox®, a liver cancer drug developed by Celsion Corporation, in a deal potentially worth hundreds of million of dollars; Simcere sold its 35% stake in Shanghai Celgen Bio-Pharmaceutical for $48.6 million; Huapont Pharma will partner with Yes Biotech, a Canadian company, to develop a new psoriasis treatment; Xceleron of the US and Crystal Pharmatech of Suzhou formed an early-stage CRO partnership; Wilex, a US diagnostics marker, engaged GeneDiagnostics to distribute its cancer biomarker test; Sihuan Pharma received SFDA approval to begin clinical trials of its innovative antibiotic; and Can-Fite Biopharma, an Israeli firm, will transfer its drug production to China. More details….

Stock Symbols: (SHA: 600267) (NSDQ: CLSN) (NYSE: SCR) (SHE: 002004) (HK: 0460) (TASE: CFBI; OTCBB: CANFY)



Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES